ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,256Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 1448

$508K Total Retail Price of All Prescriptions

Rank: 126 out of 1448

463 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 463 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

28% of this provider’s 463 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 10,928 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 606 505 S3 1 33
LISINOPRIL 588 517 2 5
LOVASTATIN 557 501 3 35
OMEPRAZOLE 514 472 4 23
LEVOTHYROXINE SODIUM 472 434 5 21
SIMVASTATIN 399 397 6 3
FUROSEMIDE 364 349 7 7
AMLODIPINE BESYLATE 323 308 8 2
ATENOLOL 315 303 9 12
GLIPIZIDE 243 229 10 75
TRIAMTERENE-HCTZ 226 206 11 55
WARFARIN SODIUM 223 200 12 8
METFORMIN HCL 221 210 13 25
METOPROLOL TARTRATE 212 204 14 9
ZOLPIDEM TARTRATE 175 142 15 34
ALENDRONATE SODIUM 163 152 16 41
DILTIAZEM 24HR ER 135 116 17 52
POTASSIUM CHLORIDE 129 111 18 19
HYDROCHLOROTHIAZIDE 124 107 19 18
GABAPENTIN 123 110 20 51
AMIODARONE HCL 122 107 21 22
GEMFIBROZIL 118 110 22 127
PAROXETINE HCL 117 107 23 121
TERAZOSIN HCL 111 91 24 116
TAMSULOSIN HCL 109 109 25 46
IBUPROFEN 103 79 26 85
DONEPEZIL HCL 102 102 27 68
PROAIR HFA 101 94 28 104
CIPROFLOXACIN HCL 97 88 29 137
RANITIDINE HCL 94 81 30 109
AMOXICILLIN 92 86 31 142
CLOPIDOGREL 90 90 32 10
CARISOPRODOL 82 61 R 33 176
DIGOXIN 82 79 33 13
ALLOPURINOL 75 70 35 43
TRAZODONE HCL 74 62 36 128
ISOSORBIDE MONONITRATE ER 73 72 37 16
AZITHROMYCIN 72 65 38 76
OXYBUTYNIN CHLORIDE 68 61 39 210
CLONIDINE HCL 68 64 39 45
ESTRADIOL 66 56 R 41 198
KLOR-CON 10 65 57 42 102
VERAPAMIL ER 63 63 43 88
ADVAIR DISKUS 62 53 44 74
ENALAPRIL MALEATE 62 62 44 48
TEMAZEPAM 58 45 46 229
BENAZEPRIL HCL 58 54 46 26
FLUOXETINE HCL 57 57 48 164
ATORVASTATIN CALCIUM 56 53 49 4
HYDROMORPHONE HCL 56 42 S2 49 278
LEVOXYL 55 55 51 213
CAPTOPRIL 54 52 52 115
ACETAMINOPHEN-CODEINE 54 49 S3 52 113
LORAZEPAM 54 41 52 254
PRAVASTATIN SODIUM 53 50 55 20
PLAVIX 52 52 56 14
DILTIAZEM 24HR CD 52 48 56 61
KLOR-CON M20 51 51 58 161
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.